Schedule 13G ownership disclosure

Aclaris Therapeutics Inc

Security class unavailable · CUSIP: 00461U105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,268,178
Percent of class
7.6100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-21-000160
Form type
SC 13G/A
Filer
Aclaris Therapeutics, Inc.
CIK
CIK 1557746
Filed
Feb 11, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub